Cosmetics

Distribution by Scientific Domains


Selected Abstracts


Precongress Symposium Adverse Reactions to Cosmetics and Perfumes

CONTACT DERMATITIS, Issue 2008
Article first published online: 27 MAY 200
First page of article [source]


Cosmetics and contact dermatitis

DERMATOLOGIC THERAPY, Issue 3 2001
Ronni Wolf
Modern cosmetic and skin care products are safe for most users and adverse reactions to them are very rare considering the number of people in contact with numerous products over a lifetime of use. Improvements in safety, tolerance, and skin compatibility will not prevent cosmetic product side effects from increasing in the future because of the continuing goals of intensifying their biological activity and therapeutic efficacy. Therefore, now more than ever, dermatologists should be familiar with all possible untoward reactions to cosmetics. Adverse reactions include an extreme variant of sensitive skin, called "cosmetic intolerance syndrome," describing individuals who are no longer able to tolerate a wide range of cosmetic products. "True" allergic reactions to cosmetics occur much less commonly than irritant reactions. These are of great importance to the dermatologist because they are more serious, more difficult to treat, and require absolute abstention from the causative agent. Eczematous, damaged skin is especially prone to develop allergies. [source]


Quantitation of suspected allergens in fragrances (Part I): evaluation of comprehensive two-dimensional gas chromatography for quality control

FLAVOUR AND FRAGRANCE JOURNAL, Issue 2 2004
Robert Shellie
Abstract An evaluation of comprehensive two-dimensional (2D) gas chromatography (GC×GC) was performed to assess its suitability for the analysis of volatile fragrance components, recognized by the European Commission's Scienti,c Committee on Cosmetics and other Non-food Products (SCCNFP) as possible skin sensitizers. The 24 volatile components listed by the SCCNFP were baseline-resolved or better within one 30 min analysis. High-quality calibration data for standard mixtures were obtained, with R2 > 0.998 over the concentration range 2,1000 mg/l. However, the analysis of small spiked amounts of target compounds in truly complex fragrances was problematic, due to uncertainty in component assignment. The bene,ts and limitations of GC×GC are reported, and a discussion of the proposed directions for the solution of this analysis is provided. Copyright © 2004 John Wiley & Sons, Ltd. [source]


Human exposure to phthalates via consumer products

INTERNATIONAL JOURNAL OF ANDROLOGY, Issue 1 2006
TED SCHETTLER
Summary Phthalate exposures in the general population and in subpopulations are ubiquitous and widely variable. Many consumer products contain specific members of this family of chemicals, including building materials, household furnishings, clothing, cosmetics, pharmaceuticals, nutritional supplements, medical devices, dentures, children's toys, glow sticks, modelling clay, food packaging, automobiles, lubricants, waxes, cleaning materials and insecticides. Consumer products containing phthalates can result in human exposures through direct contact and use, indirectly through leaching into other products, or general environmental contamination. Historically, the diet has been considered the major source of phthalate exposure in the general population, but all sources, pathways, and their relative contributions to human exposures are not well understood. Medical devices containing di-(2-ethylhexyl) phthalate are a source of significant exposure in a susceptible subpopulation of individuals. Cosmetics, personal care products, pharmaceuticals, nutritional supplements, herbal remedies and insecticides, may result in significant but poorly quantified human exposures to dibutyl phthalate, diethyl phthalate, or dimethyl phthalate. Oven baking of polymer clays may cause short-term, high-level inhalation exposures to higher molecular weight phthalates. [source]


,Health Not Cosmetics': a medical student obesity treatment project

MEDICAL EDUCATION, Issue 11 2006
José E Rodríguez
No abstract is available for this article. [source]


Formaldehyde-releasers in cosmetics: relationship to formaldehyde contact allergy

CONTACT DERMATITIS, Issue 1 2010
Part 1.
In this part of a series of review articles on formaldehyde-releasers and their relationship to formaldehyde contact allergy, formaldehyde-releasers in cosmetics are discussed. In this first part of the article, key data are presented including frequency of sensitization and of their use in cosmetics. In Europe, low frequencies of sensitization have been observed to all releasers: 2-bromo-2-nitropropane-1,3-diol 0.4,1.2%, diazolidinyl urea 0.5,1.4%, imidazolidinyl urea 0.3,1.4%, quaternium-15 0.6,1.9% (for DMDM hydantoin no recent data are available). All releasers score (far) higher prevalences in the USA; the possible explanations for this are discussed. The relevance of positive patch test reactions has been insufficiently investigated. In the USA, approximately 20% of cosmetics and personal care products (stay-on products: 17%, rinse-off products 27%) contain a formaldehyde-releaser. The use of quaternium-15 is decreasing. For Europe, there are no comparable recent data available. In the second part of the article, the patch test relationship of the releasers in cosmetics to formaldehyde contact allergy will be reviewed and it will be assessed whether products preserved with formaldehyde-releasers may contain enough free formaldehyde to pose a threat to individuals who have contact allergy to formaldehyde. [source]


Formaldehyde-releasers: relationship to formaldehyde contact allergy.

CONTACT DERMATITIS, Issue 2 2009
Contact allergy to formaldehyde, inventory of formaldehyde-releasers
This is one of series of review articles on formaldehyde and formaldehyde-releasers (others: formaldehyde in cosmetics, in clothes and in metalworking fluids and miscellaneous). Thirty-five chemicals were identified as being formaldehyde-releasers. Although a further seven are listed in the literature as formaldehyde-releasers, data are inadequate to consider them as such beyond doubt. Several (nomenclature) mistakes and outdated information are discussed. Formaldehyde and formaldehyde allergy are reviewed: applications, exposure scenarios, legislation, patch testing problems, frequency of sensitization, relevance of positive patch test reactions, clinical pattern of allergic contact dermatitis from formaldehyde, prognosis, threshold for elicitation of allergic contact dermatitis, analytical tests to determine formaldehyde in products and frequency of exposure to formaldehyde and releasers. The frequency of contact allergy to formaldehyde is consistently higher in the USA (8,9%) than in Europe (2,3%). Patch testing with formaldehyde is problematic; the currently used 1% solution may result in both false-positive and false-negative (up to 40%) reactions. Determining the relevance of patch test reactions is often challenging. What concentration of formaldehyde is safe for sensitive patients remains unknown. Levels of 200,300 p.p.m. free formaldehyde in cosmetic products have been shown to induce dermatitis from short-term use on normal skin. [source]


Allergic contact dermatitis to copolymers in cosmetics , case report and review of the literature

CONTACT DERMATITIS, Issue 5 2006
Sarah Quartier
Copolymers or heteropolymers are large molecules with high molecular weights (>1000 D). They have been underestimated for a long time as to their sensitizing capacities. Allergic contact dermatitis to 6 copolymers in cosmetics and 1 in a medical dressing has been described; however, the nature of the hapten is still unknown. We report a case of allergic contact dermatitis to polyvinylpyrrolidone (PVP)/hexadecene copolymer in a purple-colored lipstick and review the literature on allergic contact dermatitis to 7 copolymers: PVP/hexadecene, PVP/eicosene, PVP/1-triacontene, methoxy polyethyleneglycol (PEG)-22/dodecyl glycols, methoxy PEG-17/dodecyl glycols, phthalic anhydride/trimellitic anhydride/glycols, and polyvinyl methyl/maleic acid anhydride. [source]


Evaluation of the skin sensitizing potency of chemicals by using the existing methods and considerations of relevance for elicitation

CONTACT DERMATITIS, Issue 1 2005
David A. Basketter
The Technical Committee of Classification and Labelling dealing with harmonized classification of substances and classification criteria under Directive 67/548/EEC on behalf of the European Commission nominated an expert group on skin sensitization in order to investigate further the possibility for potency consideration of skin sensitizers for future development of the classification criteria. All substances and preparations should be classified on the basis of their intrinsic properties and should be labelled accordingly with the rules set up in the Directive 67/548/EEC. The classification should be the same under their full life cycle and in the case that there is no harmonized classification the substance or preparation should be self-classified by the manufacturer in accordance with the same criteria. The Directive does not apply to certain preparations in the finished state, such as medical products, cosmetics, food and feeding stuffs, which are subject to specific community legislation. The main questions that are answered in this report are whether it would be possible to give detailed guidance on how to grade allergen potency based on the existing methods, whether such grading could be translated into practical thresholds and whether these could be set for both induction and elicitation. Examples are given for substances falling into various potency groups for skin sensitization relating to results from the local lymph node assay, the guinea pig maximization test, the Buehler method and human experience. [source]


FS04.5 Iodopropynylbutyl carbamate (IPBC) 0.2% is suggested for patch testing of patients with eczema possibly related to preservatives

CONTACT DERMATITIS, Issue 3 2004
Jochen Brasch
Iodopropynylbutyl carbamate (IPBC)is a preservative that has been increasingly used for skin care products and cosmetics within the last years and the first cases of contact sensitization have meanwhile been reported. Therefore, a surveillance for IPBC contact allergy is now necessary. Our study was aimed to find out a suitable test concentration of IPBC for this purpose. The data 8106 patients tested by 23 centres of the German Contact Dermatitis Research Group (DKG) and the Information Network of Departments of Dermatology (IVDK)in the time from May 2001 to July 2003 with IPBC in concentrations of 0.1%, 0.2%, 0.3%, and 0.5% were retrospectively evaluated. Criteria considered to determine the optimal test concentration of IPBC were the reaction index, the positivity ratio, the rate of crescendo reactions, and the relation of IPBC-reactions with MOAHLFA-indices, with irritant reactions to sodium lauryl sulfate, and with positive reactions to the most common standard contact allergens and 4 other preservatives. For statistical evaluations the exact McNemar test was applied and odds ratios were calculated according to the profile likelihood method, as derived from logistic regression analyses. The rate of positive reactions to IPBC increased from 0.5% with IPBC 0.1% to 1.7% with IPBC 0.5%, but there was a problem with sensitivity or specificity with both of these 2 concentrations. Therefore, we focused on IPBC 0.2%(0.8% positive reactions) and IPBC 0.3%(1.3% positive reactions) for further detailed analyses. An evaluation of the related parameters revealed that with IPBC 0.2% as compared to IPBC 0.3% a higher percentage of crescendo reactions, a higher reaction index, a lower number of doubtful reactions, a plausible association of positive reactions with reactions to other preservatives, nd no association with a pronounced skin irritability was found. In conclusion, we recommend to start with IPBC 0.2% for patch testing of all persons with contact dermatitis that may be related to preservatives. [source]


Contact dermatitis due to disodium ethylenediamine- tetraacetic acid in cosmetics and shampoo

CONTACT DERMATITIS, Issue 2 2003
Fujiko Soga
No abstract is available for this article. [source]


Contact sensitization from Compositae-containing herbal remedies and cosmetics

CONTACT DERMATITIS, Issue 4 2002
Evy Paulsen
The Compositae (Asteraceae) family of plants is currently an important cause of allergic plant contact dermatitis in Europe. The family comprises some of the oldest and most valued medicinal plants, and the increasing popularity of herbal medicine and cosmetics may theoretically result in a growing number of Compositae sensitizations from these sources. According to the literature at least 15 species, including among others arnica (Arnica montana), German and Roman chamomile (Chamomilla recutita and Chamaemelum nobile), marigold (Calendula officinalis), Echinacea and elecampane (Inula helenium), have been suspected of sensitization or elicitation of Compositae dermatitis. Epidemiological data are available for 2 species only, arnica and German chamomile, the rest of the evidence being anecdotal. Based on this, sensitization seems to occur relatively frequently with a few species such as arnica and elecampane, and occurs rarely with the majority, especially the widely used German chamomile. Sesquiterpene lactones are the most important allergens, but there are a few cases of sensitization from a coumarin, a sesquiterpene alcohol and a thiophene. The risk of elicitation of dermatitis by using Compositae-containing products in Compositae-sensitive individuals is by-and-large unknown. [source]


Medical and surgical therapies for alopecias in black women

DERMATOLOGIC THERAPY, Issue 2 2004
Valerie D. Callender
ABSTRACT:, Hair loss is a common problem that challenges the patient and clinician with a host of cosmetic, psychological and medical issues. Alopecia occurs in both men and women, and in all racial and ethnic populations, but the etiology varies considerably from group to group. In black women, many forms of alopecia are associated with hair-care practices (e.g., traction alopecia, trichorrhexis nodosa, and central centrifugal cicatricial alopecia). The use of thermal or chemical hair straightening, and hair braiding or weaving are examples of styling techniques that place African American women at high risk for various "traumatic" alopecias. Although the exact cause of these alopecias is unknown, a multifactorial etiology including both genetic and environmental factors is suspected. A careful history and physical examination, together with an acute sensitivity to the patient's perceptions (e.g., self-esteem and social problems), are critical in determining the best therapy course. Therapeutic options for these patients range from alteration of current hair grooming practices or products, to use of specific medical treatments, to hair replacement surgery. Since early intervention is often a key to preventing irreversible alopecia, the purpose of the present article is to educate the dermatologist on all aspects of therapy for hair loss in black women,including not only a discussion of the main medical and surgical therapies but also an overview of ethnic hair cosmetics, specific suggestions for alterations of hair-care practices, and recommendations for patient education and compliance. [source]


Complementary and integrative medical therapies, the FDA, and the NIH: definitions and regulation

DERMATOLOGIC THERAPY, Issue 2 2003
Michael H. Cohen
ABSTRACT: ,,The National Center for Complementary and Alternative Medicine (NCCAM) presently defines complementary and alternative medicine (CAM) as covering "a broad range of healing philosophies (schools of thought), approaches, and therapies that mainstream Western (conventional) medicine does not commonly use, accept, study, understand, or make available. The research landscape, including NCCAM-funded research, is continually changing and subject to vigorous methodologic and interpretive debates. Part of the impetus for greater research dollars in this arena has been increasing consumer reliance on CAM to dramatically expand. State (not federal) law controls much of CAM practice. However, a significant federal role exists in the regulation of dietary supplements. The U.S. Food and Drug Administration (FDA) regulates foods, drugs, and cosmetics in interstate commerce. No new "drug" may be introduced into interstate commerce unless proven "safe" and "effective" for its intended use, as determined by FDA regulations. "Foods", however, are subject to different regulatory requirements, and need not go through trials proving safety and efficacy. The growing phenomenon of consumer use of vitamins, minerals, herbs, and other "dietary supplements" challenged the historical divide between drugs and foods. The federal Dietary Supplements Health Education Act (DSHEA) allows manufacturers to distribute dietary supplements without having to prove safety and efficacy, so long as the manufacturers make no claims linking the supplements to a specific disease. State law regulates the use of CAM therapies through a variety of legal rules. Of these, several major areas of concern for clinicians are professional licensure, scope of practice, and malpractice. Regarding licensure, each state has enacted medical licensing that prohibits the unlicensed practice of medicine and thereby criminalizes activity by unlicensed CAM providers who offer health care services to patients. Malpractice is defined as unskillful practice which fails to conform to a standard of care in the profession and results in injury. The definition is no different in CAM than in general medicine; its application to CAM, however, raises novel questions. Courts rely on medical consensus regarding the appropriateness of a given therapy. A framework for assessing potential liability risk involves assessing the medical evidence concerning safety and efficacy, and then aligning clinical decisions with liability concerns. Ultimately research will or will not establish a specific CAM therapy as an important part of the standard of care for the condition in question. Legal rules governing CAM providers and practices are, in many cases, new and evolving. Further, laws vary by state and their application depends on the specific clinical scenario in question. New research is constantly emerging, as are federal and state legislative developments and judicial opinions resulting from litigation. [source]


Cosmetics and contact dermatitis

DERMATOLOGIC THERAPY, Issue 3 2001
Ronni Wolf
Modern cosmetic and skin care products are safe for most users and adverse reactions to them are very rare considering the number of people in contact with numerous products over a lifetime of use. Improvements in safety, tolerance, and skin compatibility will not prevent cosmetic product side effects from increasing in the future because of the continuing goals of intensifying their biological activity and therapeutic efficacy. Therefore, now more than ever, dermatologists should be familiar with all possible untoward reactions to cosmetics. Adverse reactions include an extreme variant of sensitive skin, called "cosmetic intolerance syndrome," describing individuals who are no longer able to tolerate a wide range of cosmetic products. "True" allergic reactions to cosmetics occur much less commonly than irritant reactions. These are of great importance to the dermatologist because they are more serious, more difficult to treat, and require absolute abstention from the causative agent. Eczematous, damaged skin is especially prone to develop allergies. [source]


Dynamic modelling of bacterial cellulose formation

ENGINEERING IN LIFE SCIENCES (ELECTRONIC), Issue 4 2009
Michael Hornung
Abstract The interest in cellulose produced by bacteria from surface cultures has increased steadily in recent years because of its potential for use in medicine and cosmetics. Unfortunately, the low yield of this production process has limited the commercial usefulness of bacterial cellulose. The aim of this paper is to show the effect of substrate mass transfer on the growth of the bacteria and on their physiological potential for product formation by means of a dynamic mathematical model. [source]


The microbial community of Vetiver root and its involvement into essential oil biogenesis

ENVIRONMENTAL MICROBIOLOGY, Issue 10 2008
Luigi Del Giudice
Summary Vetiver is the only grass cultivated worldwide for the root essential oil, which is a mixture of sesquiterpene alcohols and hydrocarbons, used extensively in perfumery and cosmetics. Light and transmission electron microscopy demonstrated the presence of bacteria in the cortical parenchymatous essential oil-producing cells and in the lysigen lacunae in close association with the essential oil. This finding and the evidence that axenic Vetiver produces in vitro only trace amounts of oil with a strikingly different composition compared with the oils from in vivo Vetiver plants stimulated the hypothesis of an involvement of these bacteria in the oil metabolism. We used culture-based and culture-independent approaches to analyse the microbial community of the Vetiver root. Results demonstrate a broad phylogenetic spectrum of bacteria, including ,-, ,- and ,- Proteobacteria, high-G+C-content Gram-positive bacteria, and microbes belonging to the Fibrobacteres/Acidobacteria group. We isolated root-associated bacteria and showed that most of them are able to grow by using oil sesquiterpenes as a carbon source and to metabolize them releasing into the medium a large number of compounds typically found in commercial Vetiver oils. Several bacteria were also able to induce gene expression of a Vetiver sesquiterpene synthase. These results support the intriguing hypothesis that bacteria may have a role in essential oil biosynthesis opening the possibility to use them to manoeuvre the Vetiver oil molecular structure. [source]


Enrichment of pomace olive oil in triterpenic acids during storage of "Alpeorujo" olive paste

EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY, Issue 12 2008
Aranzazu García
Abstract Triterpenic acids are natural compounds present in plants and foods with beneficial properties for human health and thus they are desirable in the food, cosmetics and pharmaceutical industries. Pomace olive is considered a good source of these substances. In this study, oleanolic and maslinic acids were found to be the main triterpenic acids identified in pomace olive oil obtained from stored "Alpeorujo". Determination of the two acids was achieved by a new procedure that consists of extracting the acids from the oil with a mixture of methanol/ethanol, and then separating and quantifying them by HPLC. Results showed that their concentration increased up to 16,g/kg of oil during storage of the pomace in large ponds for 7,months. The concentration of both triterpenic acids was similar in the pomace olive oil obtained by using the centrifugation system. By contrast, a much lower concentration of maslinic than oleanolic acid was detected in pomace olive oils obtained by solvent extraction from the previously centrifugated "Alpeorujo" paste. These triterpenic acids also contributed to the acidity of the crude oil. Likewise, the oil of the pomace paste was enriched in other substances such as 4-ethylphenol and aliphatic alcohols during the storage of the paste in large ponds. Consequently, crude pomace olive oil can be considered a good source of triterpenic acids when obtained from a stored olive paste. [source]


The human skin/chick chorioallantoic membrane model accurately predicts the potency of cosmetic allergens

EXPERIMENTAL DERMATOLOGY, Issue 4 2009
Dan Slodownik
Abstract:, The current standard method for predicting contact allergenicity is the murine local lymph node assay (LLNA). Public objection to the use of animals in testing of cosmetics makes the development of a system that does not use sentient animals highly desirable. The chorioallantoic membrane (CAM) of the chick egg has been extensively used for the growth of normal and transformed mammalian tissues. The CAM is not innervated, and embryos are sacrificed before the development of pain perception. The aim of this study was to determine whether the sensitization phase of contact dermatitis to known cosmetic allergens can be quantified using CAM-engrafted human skin and how these results compare with published EC3 data obtained with the LLNA. We studied six common molecules used in allergen testing and quantified migration of epidermal Langerhans cells (LC) as a measure of their allergic potency. All agents with known allergic potential induced statistically significant migration of LC. The data obtained correlated well with published data for these allergens generated using the LLNA test. The human-skin CAM model therefore has great potential as an inexpensive, non-radioactive, in vivo alternative to the LLNA, which does not require the use of sentient animals. In addition, this system has the advantage of testing the allergic response of human, rather than animal skin. [source]


Re: Assessment of principal parabens used in cosmetics after their passage through human epidermis,dermis layers (ex vivo study)

EXPERIMENTAL DERMATOLOGY, Issue 8 2008
Dene Godfrey
No abstract is available for this article. [source]


Lichen extracts as raw materials in perfumery.

FLAVOUR AND FRAGRANCE JOURNAL, Issue 2 2009
Part 1: oakmoss
Abstract A comprehensive review is presented on extracts of a lichen, oakmoss (Evernia prunastri), that are used in the fragrance industry. Analytical aspects are discussed in detail, from both qualitative and quantitative standpoints, mainly in relation to the industrial processing of the lichen. It is shown that more than 170 constituents have been identified so far in oakmoss extracts, including 47 depsides or depside-derived compounds and 25 triterpenes or steroids. A survey of industrially relevant synthetic products with an oakmoss odour is included. Toxicology issues related to the use of oakmoss extracts in cosmetics and fragrance formulations are critically reviewed. Copyright © 2009 John Wiley & Sons, Ltd. [source]


Epidemiology and carcinogenesis of hepatocellular carcinoma

HPB, Issue 1 2005
TRISHE Y.-M.
Abstract The incidence of hepatocellular carcinoma (HCC) shows marked variation worldwide but the magnitude of this tumor is reflected by the occurrence of at least 1 million new cases annually and the uniformly dismal outlook with median survivals of <25 months after resection and <6 months with symptomatic treatment. The strikingly uneven distribution of this tumor parallels the prevalence of hepatitis B infection with rising incidence in western countries attributed to hepatitis C infection. Chronic hepatitis and cirrhosis constitute the major preneoplastic conditions in the majority of HCCs and may be related to other etiologic agents such as environmental chemical carcinogens including nitrites, hydrocarbons, solvents, organochlorine pesticides, and the chemicals in processed foods, cleaning agents, cosmetics and pharmaceuticals, as well as plant toxins such as aflatoxins produced by fungi that cause spoilage of grain and food in the tropics. Genetic diseases such as genetic hematochromatosis, Wilson's disease, ,-1-antitrypsin deficiency, and the inborn errors of metabolism including hereditary tyrosinemia and hepatic porphyria, are known to be associated with HCC. Numerous genetic alterations and the modulation of DNA methylation are recognized in HCC and it is likely that these genetic and epigenetic changes combine with factors involved in chronic hepatocyte destruction and regeneration to result in neoplastic growth and multiple molecular pathways may be involved in the production of subsets of hepatocellular tumors. [source]


The Coming of Advanced Materials: A Personal View of the Contributions by Cambridge Scientists,

ADVANCED MATERIALS, Issue 38-39 2009
John Meurig Thomas
Abstract The highly significant contributions both directly and indirectly made to the study of condensed matter in general and to advanced materials in particular by a succession of Cambridge scientists over the early years of the past half century are adumbrated in the light of the conjunction of the 21st anniversary of the founding of this journal and the 800th anniversary of the University of Cambridge. So also are the reasons for the burgeoning growth in the last few decades of the preparation, characterization, and use of various kinds of advanced materials. A summary is also given of the author's own work in solid-state and materials science, including a brief appraisal of recent strategies for the design of advanced catalysts for the production (under environmentally benign conditions) of a number of industrially important chemicals ranging from vitamins to commodities, such as adipic acid and terephthalic acid, and building blocks, such as styrene oxide, that are utilized in the manufacture of cosmetics and perfumes. [source]


Combined exposures to anti-androgenic chemicals: steps towards cumulative risk assessment

INTERNATIONAL JOURNAL OF ANDROLOGY, Issue 2 2010
A. Kortenkamp
Summary There is widespread exposure to anti-androgens, a group of chemicals able to disrupt androgen action in foetal life, with irreversible de-masculinizing consequences. Substances of concern include certain phthalates, pesticides and chemicals used in cosmetics and personal care products. Although people come into contact with several anti-androgens, chemicals risk assessment normally does not take account of the effects of combined exposures. However, a disregard for combination effects may lead to underestimations of risks and for this reason, we have assessed the feasibility of conducting cumulative risk assessment, where the focus is on considering the effects of exposure to multiple chemicals, via multiple routes and pathways. Following recent recommendations by the US National Research Council, we have, for the first time, included phthalates and other anti-androgenic chemicals, a total of 15 substances. On the basis of exposure estimates for the individual chemicals and reference doses for anti-androgenicity, we have used the hazard index approach. We show that the cumulative risks from anti-androgen exposures exceed acceptable levels for people on the upper end of exposure levels. The value obtained for median exposures to the 15 substances can be judged tolerable. However, significant knowledge gaps exist that prevent us from arriving at definitive conclusions. Of greatest concern is an absence of appropriate in vivo toxicity data about large numbers of in vitro androgen receptor antagonists. Knowledge about the effect profiles of these chemicals will lead to higher risk estimates. Our analysis suggests that risk reductions can be achieved by limiting exposures to the plasticizer diethyl hexyl phthalate, the cosmetic ingredients butyl- and propyl paraben, the pesticides vinclozolin, prochloraz and procymidone and bisphenol A. [source]


Human exposure to phthalates via consumer products

INTERNATIONAL JOURNAL OF ANDROLOGY, Issue 1 2006
TED SCHETTLER
Summary Phthalate exposures in the general population and in subpopulations are ubiquitous and widely variable. Many consumer products contain specific members of this family of chemicals, including building materials, household furnishings, clothing, cosmetics, pharmaceuticals, nutritional supplements, medical devices, dentures, children's toys, glow sticks, modelling clay, food packaging, automobiles, lubricants, waxes, cleaning materials and insecticides. Consumer products containing phthalates can result in human exposures through direct contact and use, indirectly through leaching into other products, or general environmental contamination. Historically, the diet has been considered the major source of phthalate exposure in the general population, but all sources, pathways, and their relative contributions to human exposures are not well understood. Medical devices containing di-(2-ethylhexyl) phthalate are a source of significant exposure in a susceptible subpopulation of individuals. Cosmetics, personal care products, pharmaceuticals, nutritional supplements, herbal remedies and insecticides, may result in significant but poorly quantified human exposures to dibutyl phthalate, diethyl phthalate, or dimethyl phthalate. Oven baking of polymer clays may cause short-term, high-level inhalation exposures to higher molecular weight phthalates. [source]


Abstracts: The effects of Coptis japonica root extract and its key component, berberine, on human subcutaneous adipocytes

INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, Issue 5 2010
Keiko Yashiki(Tohi)
pp.274,280 An increase of subcutaneous fat presses lymph vessels and blood vessels in skin tissues, and results in not only causing skin troubles such as skin sagging and swelling but also forming cellulite that makes bodylines worse. To expand further application of plant extracts to cosmetics, we focused on inhibitory effects of subcutaneous preadipocytes differentiation and facilitating lipolysis in adipocytes. In this study, in a screening test of a number of plant extracts, Coptis japonica root extract and its key component, berberine, showed potent inhibition of triglyceride accumulation and subcutaneous preadipocytes differentiation. Furthermore, Coptis japonica root extract and berberine down-regulated the mRNA expression level of several differentiation factors derived from subcutaneous preadipocytes. Coptis japonica root extract and berberine in subcutaneous adipocytes facilitated lipolysis in mature adipocytes. Our study suggested that Coptis japonica root extract and its key component, berberine, is expected to be useful for slimming and related skin troubles such as skin sagging, swelling, cellulite, and so on. [source]


Abstracts: New alternatives to cosmetics preservation

INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, Issue 5 2010
S. Papageorgiou
pp. 107,123 This work was partially presented at the 7th Joint Meeting of AFRP, ASP, GA, PSE and SIF, Athens, Greece, and at the XIIIth COSMODERM Joint Meeting of ESCAD and the Hellenic Society of Dermatology and Venerology, Athens, Greece. In recent years, there is a considerable interest in the development of preservative-free or self-preserving cosmetics. The aim of our work was to develop new cosmetic formulations by replacing chemical preservatives with ingredients with antimicrobial properties that are not legislated as preservatives according to Annex VI of Commission Directive 76/768/EEC. This paper describes the preservative efficacy of the well-known antimicrobial extracts of Lonicera caprifoleum and Lonicera japonica in combination with glyceryl caprylate and/or levulinic acid, p-anisic acid, and ethanol. We prepared a series of acidic (pH = 5.5) aqueous and O/W formulations, i.e., tonic lotion, shampoo, shower gel, conditioning cream, anticellulite cream, cleansing milk and peeling cream, containing (0.2% w/w) Lonicera extracts, alone in the case of tonic lotion and in combination with (1% w/w) glyceryl caprylate in the other products, and we performed challenge tests according to the European Pharmacopoeia procedures and criteria. Formulations such as shampoo, shower gel, and conditioning cream fulfilled criterion A, while tonic lotion, anticellulite cream, cleansing milk, and peeling cream fulfilled criterion B, in regard to contamination from A. niger. Furthermore, we evaluated the efficacy of the antimicrobial systems in two states of use: the intact product and after 3 weeks of consumer use. The results showed that A. niger was also detected during use by consumers in the products that satisfied only criterion B in challenge tests. The addition of antimicrobial fragrance ingredients such (,0.3% w/w) levulinic acid or (0.1% w/w) p-anisic acid and/or (5% w/w) ethanol afforded products that met criterion A in challenge tests and were also microbiologically safe during use. The small quantity (5% w/w) of ethanol gave an important assistance in order to boost the self-preserving system and to produce stable and safe products. [source]


Frictional behaviors during applications of lotions by use of a novel friction meter and evaluation of tactile feeling

INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, Issue 4 2010
A. Ishikubo
Vol. 43, No.3 (2009) pp.171,176 A novel friction meter that allows us to measure normal force and friction force at the same time was developed, and the frictional behavior of cosmetics during application was investigated for an evaluation of a tactile feeling, permeability. As a result of measurements of four lotion samples by 15 panels, time courses of normal forces, friction forces and friction coefficients were different among the panels though they used the same samples. It was also found that the maximum value of differentiation in friction coefficient with better permeability feeling was larger than those with less permeability feeling. This suggests that relative changes in the time course of friction coefficients have an important influence on a tactile feeling, permeability. [source]


Microencapsulation of rosmarinic acid using polycaprolactone and various surfactants

INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, Issue 3 2010
H.-J. Kim
Synopsis Rosmarinic acid (RA) has a number of interesting biological activities, e.g. anti-viral, anti-bacterial, anti-inflammatory and antioxidant. The antioxidant activity of RA is stronger than that of vitamin E. Despite its strong antioxidant activity, it was limited to use in cosmetics because of the low water solubility, discolouration and chemical instability. The purpose of this study was to prepare RA-loaded polycaprolactone (PCL) microspheres using emulsion solvent evaporation method and characterize them with different surfactants used in the formation process. Finally, long-term stability of RA was evaluated in the cosmetic formulation. As a result, PCL microspheres were found to be spherical in shape, with zwitterionic surfactant-PCL particles being the smallest size distribution and highest entrapment efficiency of RA. Emulsions containing RA-loaded PCL microspheres showed a better long-term stability of the RA compared with those containing only RA. These results suggest that RA may be stably and efficiently encapsulated into polycaprolactone microspheres. Résumé Micro encapsulation d'acide rosmarinique utilisant la polycaprolactone et divers surfactants L'acide rosmarinique a un certain nombre d'activités biologiques intéressantes, par exemple antivirales, antibactériennes, anti-inflammatoires et antioxydantes. L'activité antioxydante de l'acide rosmarinique est plus puissante que celle de la vitamine E. Malgré sa forte activité antioxydante, son usage en cosmétique est limité en raison de sa faible solubilité dans l'eau, sa décoloration et son instabilité chimique. Le but de cette étude était de préparer des microsphères de PCL chargées d'acide rosmarinique par la méthode d'émulsification par d'évaporation de solvant et de les caractériser selon les différents surfactants utilisés dans le processus de fabrication. Enfin, la stabilitéà long terme de l'acide rosmarinique a étéévaluée dans la formulation cosmétique. Les microsphères PCL ont été trouvé de forme sphérique, avec les surfactants zwitterioniques, les particules PCL offrent une distribution de petites tailles et une efficacité de piégeage en acide rosmarinique la plus élevée. Les émulsions contenant des microsphères PCL chargées d'acide rosmarinique ont montréà long terme une meilleure stabilité en acide rosmarinique que celles contenant l'acide seul. Ces résultats suggèrent que l'acide rosmarinique peut être encapsulé de façon efficace et stable dans des microsphères de polycaprolactone. [source]


Clinical efficacy comparison of anti-wrinkle cosmetics containing herbal flavonoids

INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, Issue 2 2010
P. Chuarienthong
Synopsis Herbal anti-wrinkle cosmetics were formulated from ginkgo (Ginkgo biloba), a mixture of tea and rooibos (Camellia sinensis and Aspalathus linearis) and soybean (Glycine soja). These extracts were incorporated into the preliminary developed stable gel base with good preference. The gingko formulation was found to be more stable than the formula containing a mixture of tea and rooibos and the soybean formula. Clinical efficacies of the ginkgo formula and the formula containing a mixture of tea and rooibos were compared following 28 days of application. The ginkgo preparation increased skin moisturization (27.88%) and smoothness (4.32%) and reduced roughness (0.4%) and wrinkles (4.63%), whereas the formula containing tea and rooibos showed the best efficacy on wrinkle reduction (9.9%). In comparison to the tea and rooibos formula, gingko significantly improved skin moisturization (P = 0.05). Résumé Comparaison de l'efficacité clinique de cosmétiques antiride contenant des flavonoïdes d'origine végétale Des cosmétiques antiride d'origine végétale ont été formulés à partir de ginkgo (Ginkgo biloba), d'un mélange de thé et de rooibos (Camélia sinensis et Aspalathus linearis) et de soja (Glycine soja). Ces extraits ont été incorporés dans une base de gel stable préalablement développée. La formulation de gingko s'est révélée plus stable que les formules contenant le mélange de thé et rooibos et le soja. Les efficacités cliniques de la formule ginkgo et de la formule contenant le mélange de thé et rooibos ont été comparées après 28 jours d'application. La préparation ginkgo a augmenté l'hydratation cutanée (27.88%) et la douceur de la peau (4.32%), la rugosité a été réduite (0.4%) ainsi que les rides (4.63%). La formule contenant le mélange thé et rooibos a montré la meilleure efficacité sur la réduction de ride (9.9%). En comparaison la formule ginkgo a augmenté de façon significative (P = 0.05) l'hydratation cutanée face à la formule contenant le mélange thé et rooibos. [source]